SEARCH

SEARCH BY CITATION

References

  • 1
    Ross L. Acute kidney injury in dogs and cats. Vet Clin North Am Small Anim Pract 2011;41:114.
  • 2
    Nickolas TL, O'Rourke MJ, Yang J, et al. Sensitivity and specificity of a single emergency department measurement of urinary neutrophil gelatinase-associated lipocalin for diagnosing acute kidney injury. Ann Intern Med 2008;148:810819.
  • 3
    Langston C. Acute uremia. In: Ettinger SJ, Feldman EC, eds. Textbook of Veterinary Internal Medicine: Diseases of the Dog and the Cat, 7th ed. St. Louis, MO: Saunders Elsevier; 2010:19691984.
  • 4
    Chertow GM, Burdick E, Honour M, et al. Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. J Am Soc Nephrol 2005;16:33653370.
  • 5
    Segev G, Kass PH, Francey T, Cowgill LD. A novel clinical scoring system for outcome prediction in dogs with acute kidney injury managed by hemodialysis. J Vet Intern Med 2008;22:301308.
  • 6
    Price R. Early markers of nephrotoxicity. Comp Clin Pathol 2002;11:27.
  • 7
    Forterre S, Raila J, Schweigert FJ. Protein profiling of urine from dogs with renal disease using proteinchip analysis. J Vet Diagn Invest 2004;16:271277.
  • 8
    Smets PMY, Meyer E, Maddens BEJ, et al. Urinary markers in healthy young and aged dogs and dogs with chronic kidney disease. J Vet Intern Med 2010;24:6572.
  • 9
    Nabity MB, Lees GE, Cianciolo R, et al. Urinary biomarkers of renal disease in dogs with X-linked hereditary nephropathy. J Vet Intern Med 2012;26:282293.
  • 10
    Mishra J, Dent C, Tarabishi R, et al. Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery. Lancet 2005;365:12311238.
  • 11
    Bolignano D, Lacquaniti A, Coppolino G, et al. Neutrophil gelatinase-associated lipocalin (NGAL) and progression of chronic kidney disease. Clin J Am Soc Nephrol 2009;4:337344.
  • 12
    Haase M, Haase-Fielitz A, Bellomo R, Mertens PR. Neutrophil gelatinase-associated lipocalin as a marker of acute renal disease. Curr Opin Hematol 2011;18:1118.
  • 13
    Yilmaz A, Sevketoglu E, Gedikbasi A, et al. Early prediction of urinary tract infection with urinary neutrophil gelatinase associated lipocalin. Pediatr Nephrol 2009;24:23872392.
  • 14
    Lee YJ, Hu YY, Lin YS, et al. Urine neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute canine kidney injury. BMC Vet Res 2012;8:248256.
  • 15
    Segev G, Palm C, Leroy B, et al. Evaluation of neutrophil gelatinase-associated lipocalin as a marker of kidney injury in dogs. J Vet Intern Med 2013;27:13621367.
  • 16
    Kai K, Yamaguchi T, Yoshimatsu Y, et al. Neutrophil gelatinase-associated lipocalin, a sensitive urinary biomarker of acute kidney injury in dogs receiving gentamicin. J Toxicol Sci 2013;38:269277.
  • 17
    Haller M, Müller W, Estelberger W, Arnold P. Single-injection inulin clearance - a simple method for measuring glomerular filtration rate in dogs. Res Vet Sci 1998;64:151156.
  • 18
    Geigy CA, Schweighauser A, Doherr M, Francey T. Occurrence of systemic hypertension in dogs with acute kidney injury and treatment with amlodipine besylate. J Small Anim Pract 2011;52:340346.
  • 19
    Polzin DJ. Chronic kidney disease. In: Ettinger SJ, Feldman EC, eds. Textbook of Veterinary Internal Medicine: Diseases of the Dog and the Cat, 7th ed. St. Louis, MO: Saunders Elsevier; 2010:19902021.
  • 20
    Kjeldsen L, Johnsen AH, Sengelov H, Borregaard N. Isolation and primary structure of NGAL, a novel protein associated with human neutrophil gelatinase. J Biol Chem 1993;268:1042510432.
  • 21
    Mishra J. Identification of neutrophil gelatinase-associated lipocalin as a novel early urinary biomarker for ischemic renal injury. J Am Soc Nephrol 2003;14:25342543.
  • 22
    Grigoryev DN, Liu M, Hassoun HT, et al. The local and systemic inflammatory transcriptome after acute kidney injury. J Am Soc Nephrol 2008;19:547558.
  • 23
    Devarajan P. Review: Neutrophil gelatinase-associated lipocalin: A troponin-like biomarker for human acute kidney injury. Nephrology 2010;15:419428.
  • 24
    Bolignano D, Donato V, Lacquaniti A, et al. Neutrophil gelatinase-associated lipocalin (NGAL) in human neoplasias: A new protein enters the scene. Cancer Lett 2010;288:1016.
  • 25
    Mori K, Nakao K. Neutrophil gelatinase-associated lipocalin as the real-time indicator of active kidney damage. Kidney Int 2007;71:967970.
  • 26
    Bolignano D, Lacquaniti A, Coppolino G, et al. Neutrophil gelatinase-associated lipocalin reflects the severity of renal impairment in subjects affected by chronic kidney disease. Kidney Blood Press Res 2008;31:255258.
  • 27
    Wagener G, Minhaz M, Mattis FA, et al. Urinary neutrophil gelatinase-associated lipocalin as a marker of acute kidney injury after orthotopic liver transplantation. Nephrol Dial Transplant 2011;26:17171723.
  • 28
    Fjaertoft G, Foucard T, Xu S, Venge P. Human neutrophil lipocalin (HNL) as a diagnostic tool in children with acute infections: A study of the kinetics. Acta Paediatr 2005;94:661666.
  • 29
    Keatings VM, Barnes PJ. Granulocyte activation markers in induced sputum: Comparison between chronic obstructive pulmonary disease, asthma, and normal subjects. Am J Respir Crit Care Med 1997;155:449453.